A large-scale, international, multicentre, phase 3 clinical trial of aspirin for the secondary prevention of colorectal cancer has concluded. Led by Singapore clinician-scientists, the ASCOLT (Aspirin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results